Insider buying
~$104K209K sh @ $0.4956
Traded Nov 13 · filed 5 days later
A major shareholder of Pasithea Therapeutics paid $104K out of pocket for Pasithea Therapeutics shares. Shares held went up 6% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Sep 30, 2026 · Filed Nov 16, 2026
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider buying
Traded Nov 13 · filed 5 days later
A major shareholder of Pasithea Therapeutics paid $104K out of pocket for Pasithea Therapeutics shares. Shares held went up 6% with this purchase.
Insider buying
Largest insider buy since 2022Traded Nov 17 · filed 1 day later
A major shareholder of Pasithea Therapeutics paid $411K out of pocket for Pasithea Therapeutics shares. Shares held went up 19% with this purchase.
Insider buying
Largest insider buy since 2022Traded Nov 16 · filed 2 days later
A major shareholder of Pasithea Therapeutics paid $291K out of pocket for Pasithea Therapeutics shares. Shares held went up 14% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.